Related references
Note: Only part of the references are listed.The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
Christoph Garbers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Identification of Canonical Tyrosine-dependent and Non-canonical Tyrosine-independent STAT3 Activation Sites in the Intracellular Domain of the Interleukin 23 Receptor
Doreen M. Floss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hitting a complex target: an update on interleukin-6 trans-signalling
Georg H. Waetzig et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma Is Inhibited by an Anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 Signaling
Jan Sommer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation
Sandra Vorlova et al.
MOLECULAR CELL (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Lipopolysaccharide-induced radical formation in the striatum is abolished in Nox2 gp91phox-deficient mice
Hans-Willi Clement et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130
Stephanie Tenhumberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing
Bin Tian et al.
GENOME RESEARCH (2007)
gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexes
Stephanie Tenhumberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
IL-6 transsignaling:: The in vivo consequences
SA Jones et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Dynamics of the gp130 cytokine complex:: A model for assembly on the cellular membrane
A Schroers et al.
PROTEIN SCIENCE (2005)
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
LK Shawver et al.
CANCER CELL (2002)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis
M Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Share Paper
